Novonix firms plans for new synthetic graphite manufacturing plant in Tennessee

[ad_1] TBE/iStock Editorial via Getty Images Novartis (NYSE:NVS) said the U.S. Court of Appeals for the Federal Circuit has upheld the company’s U.S. combination patent for its blockbuster cardiac drug Entresto, also known as sacubitril/valsartan. The Swiss drugmaker said it will work to enforce the patent [ad_2]

[ad_1] PRWire: Dubai, United Arab Emirates, 24 September 2024 – As Latin America and the Middle East navigate an increasingly interconnected global economy, the SuperBridge Summit 2024 is set to play a pivotal role in forging new trade and investment partnerships between these dynamic regions. Organized by the Dubai World Trade Centre (DWTC) and the…